Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
nbm-bmx (3 trials)
temozolomide (temodar) (1 trial)
Neoplasms (Phase 1)
Trials (3 total)
Trial APIs (2 total)